Pulmonary Medicine

  2090-1844

  2090-1836

  Ai cập

Cơ quản chủ quản:  Hindawi Limited , HINDAWI LTD

Lĩnh vực:
Pulmonary and Respiratory MedicineMedicine (miscellaneous)

Phân tích ảnh hưởng

Thông tin về tạp chí

 

Pulmonary Medicine is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology. The journal encourages submissions on pulmonology, respiratory medicine, thoracic surgery, lung diseases, pulmonary function tests, and respiratory care and therapy.

Các bài báo tiêu biểu

Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis
Tập 2014 - Trang 1-22 - 2014
Tim O. Hirche, Christian Benden, Helge Hebestreit, D. Shimmin, Amparó Solé, J.S. Elborn, Helmut Ellemunter, Paul Aurora, Michael Hogardt, Thomas Wagner, ECORN-CF Study Group
There are no European recommendations on issues specifically related to lung transplantation (LTX) in cystic fibrosis (CF). The main goal of this paper is to provide CF care team members with clinically relevant CF-specific information on all aspects of LTX, highlighting areas of consensus and controversy throughout Europe. Bilateral lung transplantation has been shown to be an important therapeutic option for end-stage CF pulmonary disease. Transplant function and patient survival after transplantation are better than in most other indications for this procedure. Attention though has to be paid to pretransplant morbidity, time for referral, evaluation, indication, and contraindication in children and in adults. This review makes extensive use of specific evidence in the field of lung transplantation in CF patients and addresses all issues of practical importance. The requirements of pre-, peri-, and postoperative management are discussed in detail including bridging to transplant and postoperative complications, immune suppression, chronic allograft dysfunction, infection, and malignancies being the most important. Among the contributors to this guiding information are 19 members of the ECORN-CF project and other experts. The document is endorsed by the European Cystic Fibrosis Society and sponsored by the Christiane Herzog Foundation.
Tube Thoracostomy: Complications and Its Management
Tập 2012 - Trang 1-10 - 2012
Emeka B. Kesieme, Andrew E. Dongo, N Ezemba, Eshiobo Irekpita, NJ Jebbin, Chinenye N. Kesieme
Background. Tube thoracostomy is widely used throughout the medical, surgical, and critical care specialities. It is generally used to drain pleural collections either as elective or emergency. Complications resulting from tube thoracostomy can occasionally be life threatening.Aim. To present an update on the complications and management of complications of tube thoracostomy.Methods. A review of the publications obtained from Medline search, medical libraries, and Google on tube thoracostomy and its complications was done.Results. Tube thoracostomy is a common surgical procedure which can be performed by either the blunt dissection technique or the trocar technique. Complication rates are increased by the trocar technique. These complications have been broadly classified as either technical or infective. Technical causes include tube malposition, blocked drain, chest drain dislodgement, reexpansion pulmonary edema, subcutaneous emphysema, nerve injuries, cardiac and vascular injuries, oesophageal injuries, residual/postextubation pneumothorax, fistulae, tumor recurrence at insertion site, herniation through the site of thoracostomy, chylothorax, and cardiac dysrhythmias. Infective complications include empyema and surgical site infection.Conclusion. Tube thoracostomy, though commonly performed is not without risk. Blunt dissection technique has lower risk of complications and is hence recommended.
Amiloride-Sensitive Sodium Channels and Pulmonary Edema
Tập 2011 - Trang 1-8 - 2011
Mike Althaus, Wolfgang Clauss, Martin Fronius
The development of pulmonary edema can be considered as a combination of alveolar flooding via increased fluid filtration, impaired alveolar-capillary barrier integrity, and disturbed resolution due to decreased alveolar fluid clearance. An important mechanism regulating alveolar fluid clearance is sodium transport across the alveolar epithelium. Transepithelial sodium transport is largely dependent on the activity of sodium channels in alveolar epithelial cells. This paper describes how sodium channels contribute to alveolar fluid clearance under physiological conditions and how deregulation of sodium channel activity might contribute to the pathogenesis of lung diseases associated with pulmonary edema. Furthermore, sodium channels as putative molecular targets for the treatment of pulmonary edema are discussed.